3Boccardo F, Lunardi GL, Petti AR, et al. Enterolactone in breast cyst fluid: Correlation with EGF and breast cancer risk. Breast Cancer Research and Treatment, 2003, 179: 17.
4周艳.乳腺积乳囊肿误诊12例分析[J].临床医学,2001,21(2):46-46.
5Cosgrove DO, Kedar PP, et al. Breast disease: Color Doppler US in differential diagnosin J. Radiology, 1993, 189: 99-104.
6Lamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneous stereotactic biopsy of histologically benign Lesions evident on follow-up mammograms. AJR, 2000, 174: 753.
7Lucas J H, Cone D L. Breast cyst aspiration. Am Fam Physi-cian,2003, 68: 1983.
5De Moraes Sehenka NG. p63 and CD10 :reliable markers in discrim- inating benign selerosing lesions from tubular carcinoma of the breast[ J ]. Appl Immunohistochem Mol Morphol, 2006,14 ( 1 ) : 71 -77.
6Raza S, Chikarmane SA, Neilsen SS, et al. BI-RADS 3,4, and le- sions : value of US in management-follow-up and outcome [ J ]. Ra-di- ology, 2008,248 ( 3 ) :773 - 781.
7Lander MR,Tabar L. Automated 3-D breast ultrasound as a promis- ing adjunctive screening tool for examining dense breast tissue[ J]. Semin Roentgenol.2011.46(47:302-308.
8Sasano H, Ozaki M. Aromatase expressing and its Localization in hu- man breast cancer [ J ]. Steroid Biochem Mol Bid, 1997,61 ( 3 ) :293.
9Cericatto R. Estrogen receptor-alpha, bcl - 2 and c-myc gene cxpres- sion in fibroadenomas and adjacent normal breast : association with nodule size, hormonal and reproductive features[ J ]. Steroids ,2005, 70(3) :153 -160.
